Pembrolizumab Plus Lenvatinib in REcurrent ccRCC Patients Failing permbroLizUmab aDjuvant trEatment
Clinical trial NCT07460206 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07460206
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2031-08-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.